Services
Research coverage of emerging companies' stock is the starting point where the "eventuality" of an investment decision begins.
Scimitar improves investor communication and capitalization by analyzing and disseminating insightful, objective, though-provoking research to the numerous asset managing classes.
The central focus for Scimitar is optimizing the short, near and long term potential of an investment opportunity. Investors and shareholders need independent verification and analyst reporting as one major source of verification that emerging healthcare companies are meeting milestones and reaching established goals.
Scimitar's comprehensive equity research is based on multiple approaches: detailed diligence, skepticism, translating expectation versus anticipation, evaluation and objectivity. We also remain open minded to contrary information as we initiate a thorough examination of the collected "intelligence" to develop an investment thesis.
We strive for accuracy and completeness and restrict any influence or pressure for our investment thesis and valuation models. We are fully and solely committed to providing accurate and relevant insight.
Independent Equity Research
Scimitar Equity, LLC is an independent equity research firm focused on providing value-added intelligence and insightful investment conclusions on emerging companies demonstrating real progress toward their vision while meeting quarterly expectation.